PMID- 31316508 OWN - NLM STAT- MEDLINE DCOM- 20201015 LR - 20201015 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 10 DP - 2019 TI - Role of Dual-Specificity Phosphatase 1 in Glucocorticoid-Driven Anti-inflammatory Responses. PG - 1446 LID - 10.3389/fimmu.2019.01446 [doi] LID - 1446 AB - Glucocorticoids (GCs) potently inhibit pro-inflammatory responses and are widely used for the treatment of inflammatory diseases, such as allergies, autoimmune disorders, and asthma. Dual-specificity phosphatase 1 (DUSP1), also known as mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1), exerts its effects by dephosphorylation of MAPKs, i.e., extracellular-signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK). Endogenous DUSP1 expression is tightly regulated at multiple levels, involving both transcriptional and post-transcriptional mechanisms. DUSP1 has emerged as a central mediator in the resolution of inflammation, and upregulation of DUSP1 by GCs has been suggested to be a key mechanism of GC actions. In this review, we discuss the impact of DUSP1 on the efficacy of GC-mediated suppression of inflammation and address the underlying mechanisms. FAU - Hoppstadter, Jessica AU - Hoppstadter J AD - Department of Pharmacy, Pharmaceutical Biology, Saarland University, Saarbrucken, Germany. FAU - Ammit, Alaina J AU - Ammit AJ AD - Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW, Australia. AD - Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, NSW, Australia. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20190626 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 0 (Glucocorticoids) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - EC 3.1.3.48 (DUSP1 protein, human) RN - EC 3.1.3.48 (Dual Specificity Phosphatase 1) SB - IM MH - Dual Specificity Phosphatase 1/*immunology MH - Extracellular Signal-Regulated MAP Kinases/immunology MH - Gene Expression Regulation, Enzymologic/*immunology MH - Glucocorticoids/*immunology MH - Humans MH - Inflammation/immunology/pathology MH - MAP Kinase Signaling System/*immunology PMC - PMC6611420 OTO - NOTNLM OT - COPD OT - arthritis OT - asthma OT - atherosclerosis OT - bone disease OT - infection OT - sepsis EDAT- 2019/07/19 06:00 MHDA- 2020/10/21 06:00 PMCR- 2019/01/01 CRDT- 2019/07/19 06:00 PHST- 2019/04/15 00:00 [received] PHST- 2019/06/10 00:00 [accepted] PHST- 2019/07/19 06:00 [entrez] PHST- 2019/07/19 06:00 [pubmed] PHST- 2020/10/21 06:00 [medline] PHST- 2019/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2019.01446 [doi] PST - epublish SO - Front Immunol. 2019 Jun 26;10:1446. doi: 10.3389/fimmu.2019.01446. eCollection 2019.